Charles Schwab
SNY icon

Charles Schwab’s Sanofi SNY Stock Holding History

Charles Schwab’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.1M Buy
307,977
+34,631
+13% +$1.55M ﹤0.01% 2033
2026
Q1 		$13.2M Buy
273,346
+9,721
+4% +$453K ﹤0.01% 1973
2025
Q4 		$12.8M Buy
263,625
+48,433
+23% +$2.4M ﹤0.01% 2011
2025
Q3 		$10.2M Buy
215,192
+35,737
+20% +$1.72M ﹤0.01% 2110
2025
Q2 		$8.67M Sell
179,455
-21,160
-11% -$1.08M ﹤0.01% 2088
2025
Q1 		$11.1M Buy
200,615
+48,670
+32% +$2.63M ﹤0.01% 1901
2024
Q4 		$7.33M Buy
151,945
+12,440
+9% +$633K ﹤0.01% 2151
2024
Q3 		$8.04M Buy
139,505
+33,105
+31% +$1.79M ﹤0.01% 2137
2024
Q2 		$5.16M Buy
106,400
+36,344
+52% +$1.75M ﹤0.01% 2346
2024
Q1 		$3.4M Buy
70,056
+27,824
+66% +$1.36M ﹤0.01% 2433
2023
Q4 		$2.1M Sell
42,232
-9,234
-18% -$452K ﹤0.01% 2604
2023
Q3 		$2.76M Buy
51,466
+23,744
+86% +$1.27M ﹤0.01% 2504
2023
Q2 		$1.49M Buy
27,722
+11,192
+68% +$602K ﹤0.01% 2641
2023
Q1 		$900K Buy
16,530
+7,780
+89% +$378K ﹤0.01% 2769
2022
Q4 		$424K Buy
+8,750
New +$384K ﹤0.01% 3044
2021
Q1 		– Sell
-778,576
Closed -$37.8M – 3517
2020
Q4 		$37.8M Buy
778,576
+19,528
+3% +$963K 0.02% 960
2020
Q3 		$38.1M Sell
759,048
-380
-0.1% -$19.6K 0.02% 804
2020
Q2 		$38.8M Sell
759,428
-280,563
-27% -$13.6M 0.02% 737
2020
Q1 		$45.5M Buy
1,039,991
+12,800
+1% +$612K 0.03% 563
2019
Q4 		$51.6M Sell
1,027,191
-22,800
-2% -$1.07M 0.03% 610
2019
Q3 		$48.6M Buy
1,049,991
+35,300
+3% +$1.52M 0.03% 598
2019
Q2 		$43.9M Hold
1,014,691
– – 0.03% 635
2019
Q1 		$44.9M Buy
+1,014,691
New +$43.5M 0.03% 596

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Charles Schwab's SNY Position: Q2 2026 in Review

Charles Schwab increased its Sanofi (SNY) stake by 13% in Q2 2026, buying an estimated $1.55M and bringing the position to 307,977 shares worth $13.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2033.

Charles Schwab first reported a position in SNY in Q1 2019 and has held it in 23 quarters since. The position peaked at $51.6M in Q4 2019. 714 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Charles Schwab held 307,977 shares of Sanofi worth $13.1M as of Q2 2026.
  • Charles Schwab bought 34,631 Sanofi shares in Q2 2026, an estimated $1.55M.
  • Sanofi made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2033 holding.
  • Charles Schwab first reported a position in Sanofi in Q1 2019 and has held it in 23 quarters since.
  • Charles Schwab's Sanofi position peaked at $51.6M in Q4 2019.
  • 714 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.